Company Profile
908 Devices Inc. provides purpose-built handheld mass spectrometry and fourier transform infrared (FTIR) devices for use in vital health and safety applications. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; XplorIR, a handheld device that uses FTIR spectroscopy to identify, quantify, and track gases and vapors; ThreatID, a portable FTIR device that rapidly detects and identifies approximately 28,000 unknown gas, vapor, powder, and liquid chemical hazards; ProtectIR, a handheld FTIR device that can identify approximately 23,000 solid and liquid chemical hazards; and VipIR, a handheld 3-in-1 analyzer that integrates FTIR, Raman spectroscopy, and smart spectral processing (SSP), a proprietary algorithm, to provide a single result from just one sample. It operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of Americas. The company was incorporated in 2012 and is headquartered in Burlington, Massachusetts.
Latest News
Harbour BioMed and Sinopharm Enter Strategic Collaboration to Establish Innovation R&D Consortium
Hofseth BioCare ASA: NEW PEER-REVIEWED CLINICAL STUDY ON PROGO® PUBLISHED IN BIOMEDICINES DEMONSTRATES GLP-1 BENEFITS AND AN INCREASE LEAN MUSCLE MASS
Trump economy at 18 months is a tale of shocks, resilience, and signs of stalled progress
3 dead, 4 injured after shooting at Seattle food festival
Cynthia Lummis Says Crypto Act Will Strengthen Sanctions Compliance Against North Korea-Based Hackers and Other Bad Actors
| Sector | Healthcare |
| Industry | Medical Devices |
| Website | https://908devices.com |
| Audit Risk | 4 |
| Board Risk | 6 |
| Overall Risk | 9 |
| Market Cap | 292.93M |
| Forward P/E | -24.91 |
| Trailing Annual Div. Rate | 0 |
| Trailing Annual Div. Yield | 0.00% |
| Trailing EPS | -0.97 |
| Forward EPS | -0.29 |
| Book Value | 3.59 |
| Price-to-Book | 1.99 |
| Enterprise-to-Revenue | 2.82 |
| Enterprise-to-EBITDA | -8.62 |
| Short Ratio | 9.93 |
| Earnings Date | 08/04/2026 |
| Earnings Call Date | 05/06/2026 |
| Earnings Average | -0.14 |
| Earnings Low | -0.19 |
| Earnings High | -0.08 |
| Revenue Average | 15.42M |
| Revenue Low | 15.17M |
| Revenue High | 15.60M |